Comparison of DNA and RNA substrate effects on TET2 structure

被引:6
|
作者
Leddin, Emmett M. [1 ]
Cisneros, G. Andres [1 ]
机构
[1] Univ North Texas, Dept Chem, Denton, TX 76203 USA
关键词
MOLECULAR-DYNAMICS SIMULATIONS; FIDELITY CHECKING; INSIGHT; ENZYMES; 5-FORMYLCYTOSINE; METHYLATION; MECHANISM; OXIDATION; CHARGES; AMBER;
D O I
10.1016/bs.apcsb.2019.05.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ten-eleven translocation (TET) enzymes can perform the stepwise oxidation of 5-methylcytosine (5mC) to 5-carboxylcytosine on both single-stranded (ss) and double-stranded (ds) DNA and RNA. It has been established that TET2 has a preference for ds DNA substrates, but it can catalyze the oxidation reaction on both ssDNA and RNA. The reasons for this substrate preference have been investigated for only a substrate 5mC ribonucleotide in a DNA strand, but not other nucleic acid configurations (Biochemistry 58 (2019) 411). We performed molecular dynamics simulations on TET2 with various ss and ds substrates in order to better understand the structural and dynamical reasons for TET2's preference to act on ds DNA. Our simulations show that substrates that have a ribonucleotide experience several disruptions in their overall backbone shape, hydrogen bonding character, and nonebonded interactions. These differences appear to lead to the instability of ribonucleotide in the active site, and provide further rational for TET2's experimental behavior.
引用
收藏
页码:91 / 112
页数:22
相关论文
共 50 条
  • [21] TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
    Feng, Yimei
    Li, Xiaoping
    Cassady, Kaniel
    Zou, Zhongmin
    Zhang, Xi
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [22] Insights on TET2 activity for DNA demethylation from MD simulations
    Torabifard, Hedieh
    Liu, Monica Yan
    Kohli, Rahul
    Cisneros, Gerardo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [23] TET2 promotor methylation and TET2 protein expression in pediatric posterior fossa ependymoma
    Pierscianek, Daniela
    Teuber-Hanselmann, Sarah
    Ahmadipour, Yahya
    Oppong, Marvin Darkwah
    Unteroberdoerster, Meike
    Mueller, Oliver
    Jabbarli, Ramazan
    Sure, Ulrich
    Zhu, Yuan
    El Hindy, Nicolai
    NEUROPATHOLOGY, 2020, 40 (02) : 138 - 143
  • [24] Cooperative effects of BCOR and TET2 mutations in myeloid malignancies
    Schaefer, E. J.
    Fares, I.
    Cejas, P.
    Font-Tello, A.
    Meyer, C. A.
    Long, H. W.
    Lindsley, R. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 18 - 18
  • [25] TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes
    Gurnari, Carmelo
    Pagliuca, Simona
    Guan, Yihong
    Adema, Vera
    Hershberger, Courtney E.
    Ni, Ying
    Awada, Hassan
    Kongkiatkamon, Sunisa
    Zawit, Misam
    Coutinho, Diego F.
    Zalcberg, Ilana R.
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    Minden, Mark D.
    Jansen, Joop H.
    Meggendorfer, Manja
    Haferlach, Claudia
    Jha, Babal K.
    Haferlach, Torsten
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD ADVANCES, 2022, 6 (01) : 100 - 107
  • [26] Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naive pluripotency marker
    Pantier, Raphael
    Tatar, Tulin
    Colby, Douglas
    Chambers, Ian
    LIFE SCIENCE ALLIANCE, 2019, 2 (05)
  • [27] Impact of Tet2 Deficiency, and of TET2 Mutations in Clonal Hematopoiesis, on Neutrophil/Granulocyte Immune Function
    Cook, Elina K.
    Luo, Michael
    Mewburn, Jeffrey
    Dunham-Snary, Kimberly J.
    Hindmarch, Charles
    Archer, Stephen L.
    Rauh, Michael J.
    BLOOD, 2021, 138
  • [28] Dysregulation of TET2 in hematologic malignancies
    Shigeru Chiba
    International Journal of Hematology, 2017, 105 : 17 - 22
  • [29] TET2, an “ambiguous” player in inflammation
    Ana María Espinosa-Oliva
    Miguel Angel Burguillos
    NeuralRegenerationResearch, 2020, 15 (08) : 1481 - 1482
  • [30] The Potential Equivalents of TET2 Mutations
    Pasca, Sergiu
    Jurj, Ancuta
    Zdrenghea, Mihnea
    Tomuleasa, Ciprian
    CANCERS, 2021, 13 (07)